Tech Company Financing Transactions
SetPoint Medical Funding Round
On 8/11/2025, SetPoint Medical landed $140 million in funding from Ally Bridge Group, Elevage Medical Technologies and private investors.
Transaction Overview
Company Name
Announced On
8/11/2025
Transaction Type
Venture Equity
Amount
$140,000,000
Round
Undisclosed
Investors
Ally Bridge Group (Lead Investor)
Elevage Medical Technologies (Lead Investor)
Proceeds Purpose
The company intends to use the funds to: U.S. commercialization of the recently FDA-approved SetPoint System, a neuroimmune modulation therapy for moderate-to-severe rheumatoid arthritis (RA). Advance its pipeline in other autoimmune conditions.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25101 Rye Canyon Loop
Valencia, CA 91355
USA
Valencia, CA 91355
USA
Phone
Website
Email Address
Overview
SetPoint Medical is a biomedical technology company developing neuromodulation therapies for patients with inflammatory autoimmune diseases, such as rheumatoid arthritis and Crohn's Disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Murthy Simhambhatla
Chief Medical Officer
David Chernoff
VP - Marketing
Ankit Shah
VP - Operations
John Long
VP - Product Management
William Calle
VP - R & D
Yaakov Levine
VP - Regulatory Affairs
Lusin Markaryan
Browse more venture capital transactions:
Prev: 8/11/2025: Truemeds venture capital transaction
Next: 8/11/2025: BinSentry venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs